Catalyst Wire Dossier Catalyst Wire Dossier

Envarsus XL

tacrolimus extended-release formulation · Biogen/Med? (Note: Envarsus is developed by Veloxis Pharma which is a subsidiary of PharmaStrat? If unknown, set null)
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Envarsus XL, covering 2021-01-12 to 2021-01-12. Get the full timeline:

Most recent: Clinical Trial Update: Envarsus XL Immunosuppression Following Liver Transplantation [Phase 2]

See pricing